Kathleen Turner, the celebrated actress famous for her roles in *Body Heat* and *Romancing the Stone*, has recently raised concerns about her health following a public appearance in New York City.
The 70-year-old was seen using a wheelchair and a cane during her outing, which took place in Manhattan. She was dressed casually in a black shirt, black pants, a gray sweater, and black sneakers. Initially, she used a cane as she got out of a vehicle and entered an office building. However, when she left, she was in a wheelchair, leading to worries about her well-being.
This sighting comes after a recent incident where Turner had to leave the stage during a performance of *A Little Night Music* due to feeling unwell. This raised further questions about her health, especially given her long history of serious health issues.
Turner has been candid about her battle with rheumatoid arthritis, an autoimmune disease that affects the joints and can cause severe pain. She was diagnosed during the height of her career in the early 1990s, and the illness has significantly impacted her life.
In earlier interviews, she described the severity of her symptoms while filming the 1994 film *Serial Mom*, explaining that her feet swelled to the point where she couldn’t fit into her shoes. “I couldn’t walk. I couldn’t hold a glass,” she shared. “The only way I could go up and down stairs was on my butt, pushing myself. The pain is very bad because there’s no way to sit, lie, or stand that allows you to escape it.”
Turner noted that while her condition is not life-threatening, it severely diminishes her quality of life. She turned to alcohol as a way to cope with her pain, believing it was a safer option than pain medication. “It was incredibly stupid,” she reflected, realizing later that drinking was taking away precious moments with her family. She eventually checked into rehab in 2002 and now only enjoys a cocktail occasionally.
Despite her chronic pain and the challenges of her condition, Turner has continued to work in Hollywood, albeit with fewer leading roles. She recognizes that she needs to adjust her career to manage her health better.
Turner reflected on the challenges of living with rheumatoid arthritis, but she emphasized her determination to keep going. “Yeah, but I wouldn’t accept it. I am a very stubborn woman,” she said.
She shared that she regained her strength, stating, “I got back to full strength, as full as I would ever be again. They told me I would be in a wheelchair for the rest of my life. Now, that was almost 30 years ago. And I look at what I’ve done in 30 years and I think: ‘Well, go to hell!’”
Despite her ongoing health issues, Turner’s fighting spirit has kept her active in film and theater. However, her recent appearances, along with her need for mobility aids, have led to increased public concern about her health.
Fans are undoubtedly hoping that the beloved actress, who has been open about her health struggles and her past with alcohol abuse, will continue to tackle her challenges with the same resilience and strength she has shown throughout her career.
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply